×
ADVERTISEMENT

FEBRUARY 21, 2025

Primary Immunodeficiency Treatment and Support


Originally published by our sister publication Specialty Pharmacy Continuum

By Marcus A. Banks

Two studies presented at the 2024 meeting of the Immunoglobulin National Society (IgNS), in Washington, D.C., offer new insights into treatment options for immune globulin (IG) therapy. 

Improving Primary Immunodeficiency

The first study outlined how an FDA-cleared immunoglobulin infusion set from Innovative Health Sciences aims to improve the experience of people with primary immunodeficiency (PI)